Seres Therapeutics, Inc. Other Comprehensive Income (Loss), Net of Tax
Seres Therapeutics, Inc. (MCRB) reported Other Comprehensive Income (Loss), Net of Tax of $20.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2018-11-08
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-09-30 was $20.00K, a 74.03% decline year-over-year.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-06-30 was $77.00K.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-03-31 was $40.00K.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2017-12-31 was -$47.00K.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2017 was $3.00K.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2016 was -$179.00K, a 696.67% decline from fiscal 2015.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2015 was $30.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|---|
| 2018-09-30 | $20.00K 10-Q · filed 2018-11-08 | $97.00K derived: sum of 2 quarters · filed 2018-11-08 | $137.00K 10-Q · filed 2018-11-08 | $90.00K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2018-06-30 | $77.00K 10-Q · filed 2018-08-02 | $117.00K 10-Q · filed 2018-08-02 | $70.00K derived: sum of 3 quarters · filed 2018-08-02 | $147.00K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2018-03-31 | $40.00K 10-Q · filed 2018-05-09 | -$7.00K derived: sum of 2 quarters · filed 2018-05-09 | $70.00K derived: sum of 3 quarters · filed 2018-11-08 | $45.00K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $30.00K derived: sum of 2 quarters · filed 2018-11-08 | $5.00K derived: sum of 3 quarters · filed 2018-11-08 | $3.00K 10-K · filed 2018-03-08 | |
| 2017-09-30 | $77.00K 10-Q · filed 2018-11-08 | $52.00K derived: sum of 2 quarters · filed 2018-11-08 | $50.00K 10-Q · filed 2018-11-08 | -$32.00K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | -$25.00K 10-Q · filed 2018-08-02 | -$27.00K 10-Q · filed 2018-08-02 | -$109.00K derived: sum of 3 quarters · filed 2018-08-02 | -$259.00K derived: sum of 4 quarters · filed 2018-08-02 | |
| 2017-03-31 | -$2.00K 10-Q · filed 2018-05-09 | -$84.00K derived: sum of 2 quarters · filed 2018-05-09 | -$234.00K derived: sum of 3 quarters · filed 2018-05-09 | -$259.00K derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | -$82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$232.00K derived: sum of 2 quarters · filed 2018-03-08 | -$257.00K derived: sum of 3 quarters · filed 2018-03-08 | -$179.00K 10-K · filed 2018-03-08 | |
| 2016-09-30 | -$150.00K 10-Q · filed 2017-11-08 | -$175.00K derived: sum of 2 quarters · filed 2017-11-08 | -$97.00K 10-Q · filed 2017-11-08 | -$57.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-06-30 | -$25.00K 10-Q · filed 2017-08-03 | $53.00K 10-Q · filed 2017-08-03 | $93.00K derived: sum of 3 quarters · filed 2018-03-08 | $60.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-03-31 | $78.00K 10-Q · filed 2017-05-04 | $118.00K derived: sum of 2 quarters · filed 2018-03-08 | $85.00K derived: sum of 3 quarters · filed 2018-03-08 | $77.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2015-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $7.00K derived: sum of 2 quarters · filed 2018-03-08 | -$1.00K derived: sum of 3 quarters · filed 2018-03-08 | $30.00K 10-K · filed 2018-03-08 | |
| 2015-09-30 | -$33.00K 10-Q · filed 2016-11-10 | -$41.00K derived: sum of 2 quarters · filed 2016-11-10 | -$10.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$8.00K 10-Q · filed 2015-08-10 | $23.00K 10-Q · filed 2016-08-11 | |||
| 2015-03-31 | -$8.00K 10-Q · filed 2016-08-11 | $31.00K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |